Several safety considerations should be taken when adding F-18 myocardial perfusion imaging (MPI) to radiation oncology departments…
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
SNMMI: Consider radiation safety when adding F-18 MPI to the radiation oncology suite
Several safety considerations should be taken when adding F-18 myocardial perfusion imaging (MPI) to radiation oncology departments…
-
ACS: Half of cancer mortality due to modifiable risk factors
Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer death worldwide, according to a recent report…
-
Triple-Negative Breast Lesions Turn Out to Be Myeloma
This case highlights the need for immunohistochemical profiling of patients with multiple breast nodules and a history of refractory myeloma. Medscape UK
-
SNMMI: For PET drugs, sterility assurance level bests sterility testing
Sterility testing is limited when it comes to detecting microbial contamination in PET drugs.
-
Is coronary computed tomography angiography the ideal modality for assessing the interplay between coronary physiology and plaque pathobiology
Intravascular imaging-based coronary artery modelling is today considered as the optimal approach to assess plaque morphology and examine the effect of the local hemodynamic forces on plaque progression.1 The high-fidelity models reconstructed from intravascular imaging data enable accurate evaluation of the wall shear stress (WSS) distribution, characterization of plaque phenotypes and assessment of the changes in plaque composition. However, invasive imaging has also significant limitations as…
-
FDA Approves Expanded Indications for PET Imaging Agent for Beta Amyloid Detection
tim.hodson
Tue, 06/24/2025 – 16:09
Jun. 24, 2025 — GE HealthCare has announced that the U.S. Food and Drug Administration (FDA) approved an updated label for its positron emission tomography (PET) imaging agent Vizamyl (flutemetamol F 18 injection) for beta-amyloid detection. The revised label, effective immediately, expands the indications for use, enables quantitative analysis of Vizamyl scans, and removes significant previous limitations such as monitoring patient response to an…
-
Could Brain Scans Improve RA Treatment?
(MedPage Today) — Functional MRI brain imaging could one day help identify rheumatoid arthritis (RA) patients most likely to respond to tumor necrosis factor (TNF) inhibitors and perhaps other targeted therapies, researchers said.
In a randomized…